Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
Search
Close this search box.
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
Menu
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Stem cell based small molecule therapy for Alzheimer’s disease

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Over 6 million people in the US suffer from AD. There are no drugs that prevent the death of nerve cells in AD, nor has any drug been identified that…

Continue ReadingStem cell based small molecule therapy for Alzheimer’s disease

Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…

Continue ReadingIdentifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

Human ES cell based therapy of heart failure without allogenic immune rejection

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…

Continue ReadingHuman ES cell based therapy of heart failure without allogenic immune rejection

Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients

  • Post author:
  • Post published:May 9, 2025
  • Post category:

As humans age, the ability to regenerate skeletal muscle tissue is impaired. Injuries to the musculoskeletal system that require extended periods of immobilization lead to muscle atrophy and are particularly…

Continue ReadingLocal Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients

Generation of hepatic cell from placental stem cell for congenital metabolic disorders

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Approximately 1 in 1,500 children has a congenital metabolic disorder. These inborn errors of metabolism are caused by deficiencies of different enzymes and result in accumulation of various substances inside…

Continue ReadingGeneration of hepatic cell from placental stem cell for congenital metabolic disorders

Generation of safe and therapeutically effective human induced hepatocyte-like cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Although the liver can regenerate itself, chronic or overwhelming damage can cause life-threatening liver failure. Currently, the only therapy for liver failure is liver transplantation. Because the supply of cadaveric…

Continue ReadingGeneration of safe and therapeutically effective human induced hepatocyte-like cells

Direct reprogramming towards vascular progenitors for the treatment of ischemia

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Angiogenesis or the generation of new blood vessels is a critical part of the normal healing process. Newly created vessels ensure the delivery of oxygen, nutrients, and specific repair signals…

Continue ReadingDirect reprogramming towards vascular progenitors for the treatment of ischemia

Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Autophagy is the cells mechanism for breaking down and recycling proteins. Danon disease is an inherited disorder of autophagy. Patients with this disease have major abnormalities in heart and skeletal…

Continue ReadingIdentification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease

Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells

  • Post author:
  • Post published:May 9, 2025
  • Post category:

This study addresses the cartilage defects resulting from injuries or from wear-and-tear that can eventually degenerate to osteoarthritis. This is a significant problem that impacts millions and costs in excess…

Continue ReadingTissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells

Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury

  • Post author:
  • Post published:May 9, 2025
  • Post category:

Transplantation of neuronal precursors into the central nervous system offers great promise for the treatment of neurological disorders including spinal cord injury (SCI). Among the most significant consequences of SCI…

Continue ReadingHuman ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Multimedia Resources
  • Contact Us